The Anthropic IPO Explained: What a Confidential S-1 Is, What We Know So Far, and How to Participate by Region

On June 1, 2026, Anthropic, the parent company of Claude, dropped a big piece of news: it filed IPO documents (an S-1) with the U.S. Securities and Exchange Commission (SEC). Social media immediately lit up with “it’s finally going public, can we buy it?”

Let’s put the single most important sentence up front: this is a “confidential filing,” not a public one. The documents have been handed over, but the share count, price, valuation, ticker, listing date, and even the full financials are all out of view right now. This is a completely different thing from the kind of public S-1 SpaceX filed recently, which laid out the entire financial statements the moment it was filed.

This piece follows the order in a beginner’s head: first understand what a “confidential filing” actually is and why there are no numbers yet, then lay out the only figures we can currently confirm, and finally explain how investors in different regions actually participate later. To be clear upfront, this article only helps you understand the event. If you want to get to know the company first, read What Is Anthropic?.

This article sorts its sources into three kinds: items marked [filing] are from Anthropic’s official statements or SEC primary documents, items marked [media] are from named media reports such as Reuters, CNBC, and Fortune, and items marked [calculation] are calculated from already-published figures. The three kinds are never mixed; anything that is media speculation or unconfirmed by the company (such as the listing date) is flagged explicitly.

🐧 Beginner takeaway: you don’t need to understand financials first to read an IPO. You only need to answer three questions: what does this company do, what can we actually confirm right now, and can I actually buy it. This piece follows exactly that order, and any term you don’t understand is explained in plain language below.

---

What Anthropic Actually Is, and Why Everyone Is Asking About a Listing

Anthropic is the company behind the AI assistant Claude. It was founded in 2021 by a group of people who left OpenAI, with a focus on AI safety and a target on the enterprise market. Over the past two years it has grown ferociously, with its valuation jumping in stages within six months, so “will it go public” has long been one of the market’s biggest questions. This filing is the latest chapter in that story.

What this “filing” actually was

Let’s lay out the skeleton first:

• Company: Anthropic, PBC (a public benefit corporation, the meaning of which for shareholders is explained later)
• Action: confidentially filed draft IPO documents (Form S-1) with the SEC [filing]
• Date: June 1, 2026 [filing]
• Status: confidentially filed as a draft; as of July 2026, still no public S-1 and no listing date. Share count, price, valuation, ticker, listing exchange, and listing date are all undetermined [filing]
• The company’s own words: this gives it “the option to list following the completion of the SEC’s review,” and whether it lists still depends on market conditions [filing]

Note the last two points: this is an “option,” not a “commitment”; and citing SEC Rule 135, the company specifically states that this filing “is not an offer to sell securities, nor a solicitation to subscribe” [filing]. In other words, this is the start of the process, not the end.

Why you can’t find its financials right now

Many people’s first move is to search for Anthropic’s S-1 to look at the financials, only to find nothing. Coming up empty is actually normal, because a confidential filing is designed not to be public in the first place.

In plain terms: the U.S. JOBS Act of 2012 allows a company to first hand a draft of its listing documents to the SEC for review “privately,” with sensitive information such as financials kept out of public view during the process. The advantage of doing this is that the company can go back and forth with the SEC to refine the documents without alerting competitors or showing the public sensitive numbers, while keeping the flexibility to “hold off if conditions are bad.”

So when do the financials become public? The rule is: at the latest, 15 days before the formal roadshow begins, the company must make the documents (including financials) public on the SEC’s EDGAR system. So Anthropic’s real financials won’t be laid out until it decides to move forward and gets close to listing. At this stage, every “Anthropic financial figure” you see out there does not come from this S-1.

Known vs. unknown: this is all we can confirm right now

Since the financials aren’t public yet, what can we actually confirm right now? A table is the fastest way to sort it out:

In one sentence: everything we can confirm is a “private-stage” or “self-reported” number, which is a different thing from the price you’ll be able to buy in the stock market later.

How it makes money, and what it’s worth

Although there are no IPO financials, there are a few officially confirmed numbers that can give you an outline (again, these are from private rounds and self-reporting, not IPO pricing):

• How it makes money: mainly from enterprises and developers paying to use Claude, especially driven by the explosion in coding (Claude Code) and AI agent workflows [media].
• Most recent raise: Series H raised US$65 billion at a post-money valuation of about US$965 billion, approaching US$1 trillion [filing]; measured against OpenAI’s official figure, that’s the first time it has surpassed OpenAI’s US$852 billion [calculation].
• Revenue (ARR): the company says its ARR (annualized revenue) has now exceeded US$47 billion [filing]. ARR is an “annualize the current pace” estimate, not full-year actual revenue, as the traps section explains further below.
• Who invested: Amazon and Google are long-term strategic shareholders (Amazon put in US$5 billion in this round, and Google has a separate large-scale compute agreement), alongside a long list of other institutions including Fidelity, T. Rowe Price, and Singapore’s GIC and Temasek [filing].

Compared with OpenAI and SpaceX, is it expensive?

There’s a very simple way to judge whether it’s expensive: look at “how many times annual revenue the valuation is,” just like judging a house by “how many times the annual rent the total price is.” The higher the multiple, the more you’re paying for each US$1 of revenue, and the more expensive it is.

• Anthropic: valuation of US$965 billion ÷ ARR of US$47 billion ≈ 20.5x [calculation]
• OpenAI: valuation of US$852 billion ÷ ARR of US$25 billion ≈ 34x [calculation; ARR is a media figure]

(Note: OpenAI’s US$852 billion is the post-money valuation the company officially announced on March 31, 2026 [filing]; the US$25 billion ARR figure comes from a February 2026 report by The Information, also picked up by Reuters [media], and lines up roughly with the late-March valuation date — it’s also higher than the roughly US$20 billion 2025 ARR OpenAI’s own CFO has disclosed, reflecting revenue that keeps growing.)

Here’s the key point: even though Anthropic’s total valuation (US$965 billion) is higher than OpenAI’s, on a “price per US$1 of revenue” basis, this rough-and-ready multiple actually comes out lower than OpenAI’s (20.5x < 34x). The reason is simple: its revenue itself is a good deal bigger than OpenAI’s, so a larger denominator naturally gives a lower multiple.

But “a lower multiple” doesn’t equal “should buy”: both of these are still private valuations, not prices you can buy at, and both companies are still burning a lot of cash, so the multiple is just one angle among many.

As for the comparison with SpaceX, the difference isn’t in the numbers but in transparency: SpaceX filed a public S-1 with the entire financials laid out for you to crunch (revenue, losses, every segment); Anthropic filed a confidential draft and has not made a single financial statement public to date; OpenAI also confirmed it’s on the same confidential track on June 8 [filing]. Even though all three are “IPO filings,” the amount of information you can get out of SpaceX versus these two AI companies differs a lot.

---

Where People Most Easily Get It Wrong

With the outline in hand, now read it from the other side: where are people most likely to read it wrong?

Filing a draft ≠ you can buy now

“Anthropic filed for an IPO!” is easily read as “it’s about to list, get ready to buy.” But a confidential filing only secures an option: the SEC review may take months, and the company might call it off because of market conditions. You can’t buy it until it publicly files a formal S-1, completes a roadshow, prices, and lists. Media estimate the earliest could be around fall 2026 [media], but Anthropic has given no official timeline, so treat that date as a reference, not a settled fact.

Private valuation ≠ the price you can buy at

US$965 billion is the post-money valuation of a private round, a number negotiated by a handful of large institutions, not a price you can buy at in the stock market. The true IPO pricing won’t be set until the roadshow gathers investor demand, and it could be higher or lower than the private valuation. Treating the private valuation as the “future stock price” is the most common anchoring mistake.

ARR ≠ full-year actual revenue

US$47 billion is an “ARR (annualized revenue),” meaning an annualized estimate of “the recent revenue pace multiplied by a year,” which is not equal to the money the company actually took in over a full past year. For a company still growing fast, ARR is usually well above actual full-year revenue. Media accounts of its actual revenue last year also vary, so just remember the “ARR of about US$47 billion” and don’t force a growth-multiple calculation out of it.

Listing ≠ you can sway it (public benefit corporation + trust)

This is Anthropic’s most distinctive feature, and one that post-listing shareholders absolutely must understand. It is a public benefit corporation (PBC), and its charter allows directors to balance “shareholders’ financial interests” against “the company’s public benefit mission (developing AI responsibly),” rather than looking only at the share price.

Even more crucial is that it has a Long-Term Benefit Trust (LTBT): made up of 5 trustees with no financial stake in the company, holding special Class T shares with the power to elect and remove a certain proportion of directors. Per the company’s September 2023 announcement, the trust’s authority expands in stages tied to time and fundraising milestones, and in any case, the trust will hold a majority of board seats within four years (i.e., by roughly 2027 at the latest) [filing].

Meaning: even if you buy the stock, your real voice in the company’s director elections and major direction will be more limited than at an ordinary company. Buying this stock means accepting the premise that the “mission comes first, with governance overseen by an independent trust."

"Final private round” and “fall listing” are media phrasings

You’ll see plenty of headlines saying “this is Anthropic’s final private round” or “expected to list in fall 2026.” These are mostly media speculation or characterization; Anthropic’s official announcement gives no timeline and does not say this is the final round. When you see a date, treat it as a reference, not a conclusion.

---

After the Filing: What Happened in June and July

A confidential filing isn’t the end of the story. Quite a few things have happened in the two months since — some directly related to the IPO, some that look unrelated — but all worth folding into the framework for judging it.

OpenAI Followed Suit

OpenAI officially confirmed on June 8, 2026 that it had also confidentially filed a draft S-1 with the SEC [filing] (media reports say the filing likely happened in late May, with no official word on the order relative to Anthropic’s), wording nearly identical to Anthropic’s: confirming only that the filing happened, and saying the timeline “may still be a while.” Both major AI labs are now stuck at the same stage: filed, no financials, no listing date.

The Export-Control Incident: An Unexpected Detour During IPO Prep

On June 12, Anthropic ran into something that looks unrelated to the IPO on the surface but is worth including here: a U.S. government export-control directive forced the company to “suddenly suspend” two of its models, Fable 5 and Mythos 5 [filing]. The company received the directive at 5:21 p.m. Eastern time and described itself as being told to suspend access almost immediately, affecting users worldwide right away [filing]. The suspension lasted roughly three weeks: on June 30, Anthropic announced the controls had been lifted, and access began being restored from July 1 [filing].

For anyone trying to read this IPO, it’s a reminder: during the period a company is preparing to list, regulatory risk doesn’t automatically disappear just because it’s “in the middle of the IPO process.” Regulation, national security, and geopolitics can intervene without warning, and they have nothing to do with financial health — it’s the dimension most easily overlooked, the one the financial numbers alone won’t show you.

Compute Expansion: Four Deals, and One Public Document With Hard Numbers

Anthropic has no public financials, but the compute deals it has signed over the past few months have left behind a few visible clues:

• April 6: Broadcom disclosed in an 8-K that Anthropic will source about 3.5 GW of next-generation TPU capacity through Broadcom starting in 2027 [counterparty 8-K].
• May 6 (before the filing): SpaceX agreed to let Anthropic use its Colossus 1 supercomputer [media].
• July 6: signed a 20-year lease with data-center company TeraWulf for about 401 megawatts (MW, a unit measuring data-center power capacity) of capacity, worth about US$19 billion to TeraWulf’s side of the deal, with the first block of capacity expected online in the second half of 2027 [media + counterparty’s 8-K].
• July 22: according to a Wall Street Journal report, AMD agreed to sell Anthropic tens of billions of dollars’ worth of AI servers and to invest up to US$5 billion in Anthropic; the partnership covers up to 2 GW (gigawatts, a thousand times larger than MW) of AMD’s new MI450 chips, with deliveries expected to start rolling out from 2027 [media].

Here’s a teaching point beginners easily miss: Anthropic itself is a private company and doesn’t have to disclose financials, but the moment it signs a deal with a “publicly listed company,” that public company is legally required to file with the SEC — and the numbers can’t stay hidden. TeraWulf is a U.S.-listed company, and for this deal it filed an “8-K” with the SEC. In plain terms: an 8-K is the “real-time filing” a U.S. public company must submit to the SEC immediately when a major event happens, unlike an annual or quarterly report’s regular schedule. This 8-K is currently the most specific public SEC document out there (with both a term length and a dollar figure: 20 years, 401 MW, about US$19 billion); even though it’s the counterparty’s disclosure and not Anthropic’s own financials, it’s the closest thing to a “public document” with hard numbers at this stage.

Signs of IPO Prep: From Trading Rules to Banks Jockeying for Position

Besides the hardware expansion, there are a few signals with more of a “getting ready to list” flavor:

• On July 15, CNBC reported that Goldman Sachs, Morgan Stanley, and JPMorgan are serving as lead underwriters and have begun arranging meetings between investors and management (expected to start in late July), targeting a listing as early as October, though the timeline could still change [media].
• On July 23, Reuters, citing a report from tech outlet The Information, said Anthropic is considering requiring rank-and-file employees to use “default” 10b5-1 trading plans after listing [media]. In plain terms: if the company does adopt this requirement, employees who want to sell their own shares would have to go through a pre-set automatic trading plan (a 10b5-1): while they don’t yet know any material inside information, they lock in in advance when and how much to sell, then execute on that schedule. This helps reduce the appearance of insider trading, but it’s not a guarantee of immunity, and right now it’s still only “under consideration.” Discussing this ahead of time suggests “how to manage employee trading after listing” is already a formal planning item, not a distant hypothetical.
• On July 8, reports said Bank of America is simultaneously vying to be an IPO advisor for both OpenAI and Anthropic [media]. A bank jockeying for position on both sides is consistent with the direction of IPO prep, but this kind of move could also just be routine business development — on its own, it isn’t evidence of listing timing.
• As for the listing date itself, there’s still no official answer. A Bloomberg report from late April floated “as early as October” [media], and by mid-July that had firmed up into a named underwriting syndicate and investor meetings on the calendar, but Anthropic has never officially confirmed any specific date.

As of July 24, 2026: Anthropic still has no public formal S-1, no ticker, no listing exchange, and no listing timeline. Everything is still at the stage of “confidentially filed + business expansion + prep moves.”

---

Can I Buy It? How to Participate by Region

Finally, the “mechanism”: whether you can actually buy it from where you live once it really lists. This explains channels; it is not a recommendation to buy; and it bears repeating that there isn’t even an exchange or a ticker yet, so everything below is “preparatory knowledge.”

Start with one general rule: IPO subscription (getting an allocation before listing) and buying in the market after listing are two different things. Allocations have high thresholds and scarce quantities, mostly reserved for institutions and high-net-worth clients; most retail investors in practice buy after listing.

United States

The most direct. After listing, it’s ordinary secondary-market trading. IPO subscription allocations usually go first to institutions and brokers’ high-net-worth clients, and ordinary retail investors don’t necessarily get them. On taxes, the U.S. taxes capital gains, with the rate depending on holding period and income.

Taiwan

First, separate “IPO subscription” from “buying after listing.” Pre-listing allocations are, in practice, almost unattainable for Taiwanese retail investors. The more realistic route is to wait until Anthropic formally lists and begins trading, then buy in the secondary market through two paths:

1. Sub-brokerage: a domestic broker is entrusted to “trade foreign securities,” the most common route.
2. Overseas broker: such as IBKR (Interactive Brokers), where you open a U.S. brokerage account yourself.

On costs, watch out for cross-border remittance fees and FX conversion fees; on taxes, U.S. stock dividends and capital gains count as “overseas income” under the Alternative Minimum Tax framework, and whether it is actually taxed depends on your income threshold. Tax rules and thresholds are subject to change, so check current-year regulations or professional advice before filing.

Japan

Through local brokers that support U.S. stocks (SBI, Rakuten, Monex, and others). Note: direct U.S. IPO subscription is not common, and most Japanese investors buy only after listing. Tax details differ by account type (including NISA), so it’s best to confirm with your broker.

Mainland China

The hardest. The key points:

• QDII is currently the clearest compliant channel, holding indirectly through QDII funds from domestic fund companies, but quota is limited.
• Each person has an annual US$50,000 FX purchase quota, and it generally cannot be declared for “offshore securities investment,” so this quota cannot be used to directly buy a U.S. IPO.
• The pragmatic approach is to get indirect exposure through QDII, or under a compliant setup wait until after listing and use existing compliant channels.

Regional summary: no one can buy it yet. After listing, on “who can most easily buy it,” the United States is the most direct, Taiwan (sub-brokerage / overseas brokers) and Japan are mostly post-listing purchases, and mainland China mainly relies on indirect QDII. Pre-listing IPO allocations are almost out of reach for retail investors. This section is general information only and does not constitute tax or legal advice.

---

Three Things to Remember After Reading This

The point of Anthropic’s IPO news isn’t “we can finally buy it”; it’s that “it’s actually still at a very early point in the process.” Keep three things “separate” and you won’t be carried away by the headlines:

• Separate the filing from the listing (a confidential filing only secures an option; it’s not priced, not listed, and not buyable).
• Separate the private valuation (about US$965 billion) from the market price (IPO pricing won’t be known until listing).
• Separate the ARR (about US$47 billion annualized revenue) from the full-year actual revenue (the former is an estimate, not actual receipts).

Add one more attitude: before the company publicly files a formal S-1 and lays out its financials, every number out there about its valuation and revenue is still one layer removed. Patiently waiting for the financials matters more than rushing to chase a sensational big number.

One last reminder: this piece is a breakdown to help you “understand the event,” not advice on “whether to buy.” Any investment decision should depend on your own risk tolerance, or on professional advice. To get to know the company better, read What Is Anthropic?; to understand why it operates as a public benefit corporation, read Why Anthropic Is a Public Benefit Corporation; to compare another high-profile tech IPO, read How to Read the SpaceX IPO.

---

References

• Anthropic official: announcement of confidential draft S-1 filing
• Anthropic official: Series H raise (US$65 billion, US$965 billion valuation, US$47 billion ARR)
• Anthropic official: Long-Term Benefit Trust governance structure
• SEC: JOBS Act confidential submission process FAQ
• Fortune: report on Anthropic’s confidential IPO filing
• CNBC: report on Anthropic filing its IPO prospectus
• OpenAI official: announcement of confidential draft S-1 filing
• Anthropic official: statement on export-control directive suspending Fable 5 / Mythos 5
• Anthropic official: announcement of controls lifted and Fable 5 access restored
• TeraWulf: 8-K filing on the data-center lease with Anthropic (SEC EDGAR)
• Reuters: report on Anthropic considering mandatory post-IPO 10b5-1 trading plans

Figures are from official announcements and named media reports; final IPO terms will follow Anthropic’s official S-1 when it is made public.